Flexion Therapeutics to Present at the 2018 Wells Fargo Healthcare Conference

BURLINGTON, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN) announced today that it will present at the 13th Annual Wells Fargo Securities Healthcare Conference taking place at the Westin Copley Place in Boston, Massachusetts. Michael Clayman, M.D., President and Chief Executive Officer, is scheduled to present at 10:50 a.m. ET on Wednesday, September 5, 2018. To access the live webcast and subsequent archived recording of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com. 

About Flexion Therapeutics Flexion Therapeutics (Nasdaq: FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. For the past two years, Flexion has been named one of the Best Places to Work by the Boston Business Journal, and Flexion was also recognized as a Top Place to Work in Massachusetts by The Boston Globe in 2017.

Contact:

Scott YoungVice President, Corporate Communications & Investor RelationsFlexion Therapeutics, Inc.T: 781-305-7194[email protected]

You May Also Be Interested In

• Ultragenyx Pharma (RARE) PT Lowered to $18 at Wells Fargo, Downgrades to Equalweight
• Jetour named FIBA Basketball World Cup 2027 Global Car Supplier
• Ermenegildo Zegna Group Reports First Half 2026 Revenues of €987 Million With Profit at €28 Million and Adjusted EBIT at €74 Million